110 related articles for article (PubMed ID: 17084082)
21. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.
Naganawa A; Matsui T; Ima M; Yoshida K; Tsuruta H; Yamamoto S; Yamamoto H; Okada H; Maruyama T; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Dec; 14(23):7774-89. PubMed ID: 16931028
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
[TBL] [Abstract][Full Text] [Related]
23. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.
Costa B; Trovato AE; Comelli F; Giagnoni G; Colleoni M
Eur J Pharmacol; 2007 Feb; 556(1-3):75-83. PubMed ID: 17157290
[TBL] [Abstract][Full Text] [Related]
24. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory and analgesic activities of some newly synthesized pyridinedicarbonitrile and benzopyranopyridine derivatives.
Hosni HM; Abdulla MM
Acta Pharm; 2008 Jun; 58(2):175-86. PubMed ID: 18515227
[TBL] [Abstract][Full Text] [Related]
26. Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747).
Le Bourdonnec B; Windh RT; Leister LK; Zhou QJ; Ajello CW; Gu M; Chu GH; Tuthill PA; Barker WM; Koblish M; Wiant DD; Graczyk TM; Belanger S; Cassel JA; Feschenko MS; Brogdon BL; Smith SA; Derelanko MJ; Kutz S; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
J Med Chem; 2009 Sep; 52(18):5685-702. PubMed ID: 19694468
[TBL] [Abstract][Full Text] [Related]
27. Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension.
Zhu GD; Gandhi VB; Gong J; Thomas S; Woods KW; Song X; Li T; Diebold RB; Luo Y; Liu X; Guan R; Klinghofer V; Johnson EF; Bouska J; Olson A; Marsh KC; Stoll VS; Mamo M; Polakowski J; Campbell TJ; Martin RL; Gintant GA; Penning TD; Li Q; Rosenberg SH; Giranda VL
J Med Chem; 2007 Jun; 50(13):2990-3003. PubMed ID: 17523610
[TBL] [Abstract][Full Text] [Related]
28. Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties.
Wang HL; Katon J; Balan C; Bannon AW; Bernard C; Doherty EM; Dominguez C; Gavva NR; Gore V; Ma V; Nishimura N; Surapaneni S; Tang P; Tamir R; Thiel O; Treanor JJ; Norman MH
J Med Chem; 2007 Jul; 50(15):3528-39. PubMed ID: 17585751
[TBL] [Abstract][Full Text] [Related]
29. Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors.
Huntjens DR; Spalding DJ; Danhof M; Della Pasqua OE
Eur J Pain; 2009 May; 13(5):448-57. PubMed ID: 18774319
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
31. Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).
Anderson DR; Meyers MJ; Vernier WF; Mahoney MW; Kurumbail RG; Caspers N; Poda GI; Schindler JF; Reitz DB; Mourey RJ
J Med Chem; 2007 May; 50(11):2647-54. PubMed ID: 17480064
[TBL] [Abstract][Full Text] [Related]
32. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
33. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
34. Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist.
Vidal B; Nueda A; Esteve C; Domenech T; Benito S; Reinoso RF; Pont M; Calbet M; López R; Cadavid MI; Loza MI; Cárdenas A; Godessart N; Beleta J; Warrellow G; Ryder H
J Med Chem; 2007 May; 50(11):2732-6. PubMed ID: 17469811
[TBL] [Abstract][Full Text] [Related]
35. Metabolism-based identification of a potent thrombin receptor antagonist.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee W; Kao G; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Smith-Torhan A; Alton K; Bryant M; Hsieh Y; Lau J; Palamanda J
J Med Chem; 2007 Jan; 50(1):129-38. PubMed ID: 17201416
[TBL] [Abstract][Full Text] [Related]
36. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
[TBL] [Abstract][Full Text] [Related]
37. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
[TBL] [Abstract][Full Text] [Related]
38. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
39. 2,3-Diarylthiophenes as selective EP1 receptor antagonists.
Ducharme Y; Blouin M; Carrière MC; Chateauneuf A; Côté B; Denis D; Frenette R; Greig G; Kargman S; Lamontagne S; Martins E; Nantel F; O'Neill G; Sawyer N; Metters KM; Friesen RW
Bioorg Med Chem Lett; 2005 Feb; 15(4):1155-60. PubMed ID: 15686932
[TBL] [Abstract][Full Text] [Related]
40. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
Leánez S; Hervera A; Pol O
Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
